OBJECTIVES: Hepatic encephalopathy (HE) is a major problem in patients treated with TIPS. The aim of the study was to establish whether pre-TIPS covert HE is an independent risk factor for the development of HE after TIPS. METHODS: Eighty-two consecutive cirrhotic patients submitted to TIPS were included. All patients underwent the PHES to identify those affected by covert HE before a TIPS. The incidence of the first episode of HE was estimated, taking into account the nature of the competing risks in the data (death or liver transplantation). RESULTS: Thirty-five (43%) patients developed overt HE. The difference of post-TIPS HE was highly significant (P=0.0003) among patients with or without covert HE before a TIPS. Seventy-seven percent o...
BACKGROUND A pre-emptive transjugular intrahepatic portosystemic shunt (pTIPS) reduces mortality ...
Background. Transjugular intrahepatic portosystemic shunt (TIPS) is an artificial channel from the p...
Objectives: Minimal hepatic encephalopathy (MHE) leads to deterioration in patient quality of life a...
OBJECTIVES: Hepatic encephalopathy (HE) is a major problem in patients treated with TIPS. The aim of...
Prediction of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt One of the ...
Introduction and aim: Hepatic encephalopathy (HE) is a common complication of transjugular intrahepa...
Background: Transjugular Intrahepatic Portosystemic Shunt (TIPS) is used for the management of patie...
IntroductionThe outcomes of transjugular intrahepatic portosystemic shunt (TIPS) placement in patien...
Forty-seven consecutive patients were prospectively evaluated to study the incidence of hepatic ence...
Purpose: The purpose of this study was to evaluate the outcomes of Transjugular Intrahepatic Shunt (...
Objectives Transjugular intrahepatic portosystemic shunt (TIPS) is adopted to treat refractory compl...
Hepatic encephalopathy (HE) occurs in 20-50% of patients after transjugular intrahepatic portosystem...
. Purpose. The purpose of this study was to determine the incidence and predictors of hepatic enceph...
Background: Hepatic encephalopathy (HE) is considered reversible regarding mental status but may not...
BACKGROUND & AIMS: The Inhibitory Control Test has been proposed as a tool to detect the persistence...
BACKGROUND A pre-emptive transjugular intrahepatic portosystemic shunt (pTIPS) reduces mortality ...
Background. Transjugular intrahepatic portosystemic shunt (TIPS) is an artificial channel from the p...
Objectives: Minimal hepatic encephalopathy (MHE) leads to deterioration in patient quality of life a...
OBJECTIVES: Hepatic encephalopathy (HE) is a major problem in patients treated with TIPS. The aim of...
Prediction of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt One of the ...
Introduction and aim: Hepatic encephalopathy (HE) is a common complication of transjugular intrahepa...
Background: Transjugular Intrahepatic Portosystemic Shunt (TIPS) is used for the management of patie...
IntroductionThe outcomes of transjugular intrahepatic portosystemic shunt (TIPS) placement in patien...
Forty-seven consecutive patients were prospectively evaluated to study the incidence of hepatic ence...
Purpose: The purpose of this study was to evaluate the outcomes of Transjugular Intrahepatic Shunt (...
Objectives Transjugular intrahepatic portosystemic shunt (TIPS) is adopted to treat refractory compl...
Hepatic encephalopathy (HE) occurs in 20-50% of patients after transjugular intrahepatic portosystem...
. Purpose. The purpose of this study was to determine the incidence and predictors of hepatic enceph...
Background: Hepatic encephalopathy (HE) is considered reversible regarding mental status but may not...
BACKGROUND & AIMS: The Inhibitory Control Test has been proposed as a tool to detect the persistence...
BACKGROUND A pre-emptive transjugular intrahepatic portosystemic shunt (pTIPS) reduces mortality ...
Background. Transjugular intrahepatic portosystemic shunt (TIPS) is an artificial channel from the p...
Objectives: Minimal hepatic encephalopathy (MHE) leads to deterioration in patient quality of life a...